🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main objective of the study is to evaluate the bioequivalence of a new ...
Status
Completed
Location
CROSS Research S.A., Phase I Unit
Start Date
2016-06
Trial ID
NCT02902289
Treatments Being Tested
The purpose of this trial is to assess the effect of 3 formulations on the ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2011-07
Trial ID
NCT01398475
Treatments Being Tested
This study evaluated the bioequivalence and safety of the test formulation ...
Status
Completed
Location
General Hospital of Shenyang Military Region
Start Date
2017-06-20
Trial ID
NCT07558967
The main objective of this trial is to select a formulation principle (tabl...
Status
Terminated
Location
Quotient Sciences
Start Date
2020-02-25
Trial ID
NCT04232839
The objective of this randomized, single-dose, two-way evaluation is to com...
Status
Completed
Location
Gateway Medical Research, Inc.
Start Date
2004-06
Trial ID
NCT00829712
Treatments Being Tested
Study to evaluate the pharmacokinetics and relative bioavailability of meta...
Status
Completed
Location
West China Second University Hospital, Sichuan University and Children's Hospital Zhejiang University School of Medicine
Start Date
2025-02-20
Trial ID
NCT06841926
Treatments Being Tested
The main objective of this trial is to investigate: * the relative bioavai...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2024-01-16
Trial ID
NCT06193811
This replication of the NefIgArd trial of TRF-budesonide aims to use real-w...
Status
Completed
Location
Ruijin hospital
Start Date
2023-04-24
Trial ID
NCT06589752
Treatments Being Tested
This is a prospective, cohort, multicenter study. Cohort 1 is treatment gro...
Status
Recruiting
Location
The Second Affiliated Hospital Zhejiang University School of Medicine
Start Date
2025-09-30
Trial ID
NCT07153887
Treatments Being Tested
This study is designed to assess the relative bioavailability of ABI-H2158 ...
Status
Completed
Location
Celerion
Start Date
2019-09-06
Trial ID
NCT04083716
Treatments Being Tested